In my experience run ups occur well before approval
look at the chart a Madrigal
The stock started to go up14 months prior to approval and showed a 6 fold increase almost a year before approval. Eftilagimod has all the potential of another Ozempic. If IMP 761 pans out we could be looking at a market cap in the tens of billions share prices north of $100 but this will take time, I am willing to wait.
Ann: Successful Meeting with FDA on Phase III Design in NSCLC, page-13
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.0¢ | $352.6K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 156231 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 2491 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |